Salient Private Client »

Eli Lilly & Co. shares owned by Salient Private Client

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Salient Private Client from 13F filings

Historical chart of Salient Private Client investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Salient Private Client consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Salient Private Client

Quarter filed Position value Share count Share price at filing
2018-09-30 $3.0M 28k 107.32
2018-06-30 $2.4M 28k 85.34
2018-03-31 $2.7M 34k 77.37
2017-12-31 $2.4M 28k 84.46

More positions owned by Salient Private Client

Energy Transfer Partners
Exxon Mobil Corporation (XOM)
Targa Res Corp (TRGP)
Spdr S&p 500 Etf (SPY)
Apple (AAPL)
Pepsi (PEP)
Johnson & Johnson (JNJ)
Lockheed Martin Corporation (LMT)
Select Energy Svcs Inc cl a (WTTR)
Enterprise Products Partners (EPD)
TJX Companies (TJX)
McDonald's Corporation (MCD)
iShares MSCI EAFE Index Fund (EFA)
At&t (T)
MasterCard Incorporated (MA)

View all positions for Salient Private Client

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
FMR
PRIMECAP Management Company
T. Rowe Price Associates
Jpmorgan Chase & Co
Geode Capital Management
Morgan Stanley
State Farm Mutual Automobile Insurance Company
Wellington Management Company
Bank of America Corporation
Northern Trust
Jennison Associates

View all funds holding Eli Lilly & Co.